Fischl, Anthony S <br/><br/>
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition.  [electronic resource] 

 -  Molecular cancer therapeutics  04 2019 
 - 856-867 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-18-0548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Carcinoma, Renal Cell--blood supply<br/>Cell Line, Tumor<br/>Drug Therapy, Combination<br/>Endothelial Cells--drug effects<br/>Female<br/>Humans<br/>Kidney Neoplasms--blood supply<br/>Lysophospholipids--antagonists & inhibitors<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Neovascularization, Pathologic--drug therapy<br/>Sphingosine--analogs & derivatives<br/>Sphingosine-1-Phosphate Receptors--antagonists & inhibitors<br/>Sunitinib--pharmacology<br/>Treatment Outcome<br/>Tumor Burden--drug effects<br/>Vascular Endothelial Growth Factor A--pharmacology<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays